Four subjects were treated under compassionate use provisions under this study with facilitating cell therapy (FCRx)
Four subjects were treated under compassionate use provisions under this study with facilitating cell therapy (FCRx) and living donor kidney transplant.
Study Type
EXPANDED_ACCESS
Enriched Hematopoetic Stem Cell Infusion
Northwestern Memorial Hospital
Chicago, Illinois, United States
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.